177 related articles for article (PubMed ID: 11950550)
1. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.
Hunt GE; Bergen J; Bashir M
Schizophr Res; 2002 Apr; 54(3):253-64. PubMed ID: 11950550
[TBL] [Abstract][Full Text] [Related]
2. Six-month outcome following a relapse of schizophrenia.
Bergen J; Hunt G; Armitage P; Bashir M
Aust N Z J Psychiatry; 1998 Dec; 32(6):815-22. PubMed ID: 10084346
[TBL] [Abstract][Full Text] [Related]
3. Relapse in schizophrenia: is there a relationship to substance abuse?
Gupta S; Hendricks S; Kenkel AM; Bhatia SC; Haffke EA
Schizophr Res; 1996 May; 20(1-2):153-6. PubMed ID: 8794503
[TBL] [Abstract][Full Text] [Related]
4. The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study.
Alisauskiene R; Løberg EM; Gjestad R; Kroken RA; Jørgensen HA; Johnsen E
Nord J Psychiatry; 2019; 73(4-5):281-287. PubMed ID: 31140342
[No Abstract] [Full Text] [Related]
5. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
[TBL] [Abstract][Full Text] [Related]
6. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.
Haywood TW; Kravitz HM; Grossman LS; Cavanaugh JL; Davis JM; Lewis DA
Am J Psychiatry; 1995 Jun; 152(6):856-61. PubMed ID: 7755114
[TBL] [Abstract][Full Text] [Related]
7. Assessing clinical predictions of early rehospitalization in schizophrenia.
Olfson M; Mechanic D; Boyer CA; Hansell S; Walkup J; Weiden PJ
J Nerv Ment Dis; 1999 Dec; 187(12):721-9. PubMed ID: 10665466
[TBL] [Abstract][Full Text] [Related]
8. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
9. Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis.
Norman RM; Malla AK
J Nerv Ment Dis; 2002 May; 190(5):331-4. PubMed ID: 12011614
[No Abstract] [Full Text] [Related]
10. Medication noncompliance and substance abuse among patients with schizophrenia.
Owen RR; Fischer EP; Booth BM; Cuffel BJ
Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158
[TBL] [Abstract][Full Text] [Related]
11. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.
Elbogen EB; Swanson JW; Swartz MS; Van Dorn R
J Nerv Ment Dis; 2005 Oct; 193(10):673-9. PubMed ID: 16208163
[TBL] [Abstract][Full Text] [Related]
12. Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals.
Swartz MS; Swanson JW; Hiday VA; Borum R; Wagner R; Burns BJ
Soc Psychiatry Psychiatr Epidemiol; 1998 Dec; 33 Suppl 1():S75-80. PubMed ID: 9857783
[TBL] [Abstract][Full Text] [Related]
13. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of atypical antipsychotics for substance use in schizophrenia patients.
Swanson J; Van Dorn RA; Swartz MS
Schizophr Res; 2007 Aug; 94(1-3):114-8. PubMed ID: 17587548
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service.
Malla A; Norman R; Bechard-Evans L; Schmitz N; Manchanda R; Cassidy C
Psychol Med; 2008 Nov; 38(11):1585-93. PubMed ID: 18205969
[TBL] [Abstract][Full Text] [Related]
16. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].
Ameller A; Gorwood P
Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239
[TBL] [Abstract][Full Text] [Related]
17. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
18. Substance abuse and the risk of readmission of people with schizophrenia at Amanuel Psychiatric Hospital, Ethiopia.
Bimerew MS; Sonn FC; Kortenbout WP
Curationis; 2007 Jun; 30(2):74-81. PubMed ID: 17703825
[TBL] [Abstract][Full Text] [Related]
19. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence.
Ho AP; Tsuang JW; Liberman RP; Wang R; Wilkins JN; Eckman TA; Shaner AL
Am J Psychiatry; 1999 Nov; 156(11):1765-70. PubMed ID: 10553741
[TBL] [Abstract][Full Text] [Related]
20. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
